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Case Report 
An apparently healthy 33 year old primigravida was referred at 32 weeks’ gestation to our prenatal 
diagnosis centre because of progressive distension of the fetal bowel. Within a few days, 
spontaneous bowel rupture and ascites were documented (Fig. 1). The fetal heart, which had a 
normal appearance at the routine anomaly scan at 20 weeks, developed severe dysfunction of the 
left ventricle and contained a hyperechogenic mass. Fetal echocardiogram showed dilation of the 
heart chambers and severe systolic dysfunction of the left ventricle. A myocardial infarction was 
suspected and the hyperechogenic mass was interpreted as an intraventricular thrombus (Fig. 2). 
Genetic analysis for cystic fibrosis (CF) (detection rate 94%) in the asymptomatic parents revealed 
a heterozygous status for F508del mutation in the father and for N1303K mutation in the mother. 
Because of rapid deterioration of the fetus a cesarean section was performed. Despite maximal drug 
therapy and ventilatory support, the baby died a few hours after birth of cardiogenic shock. Autopsy 
confirmed ileus rupture and diffuse meconium peritonitis. Heart examination confirmed a large 
thrombus filling most of the cavity of the left ventricle and large area of myocardial infarction 
involving the interventricular septum, the anterior and lateral wall of the left ventricle (Fig. 3). 
Investigation of the coronary system revealed endo-luminal thrombosis of the main left coronary 
artery extending into the proximal left anterior descending and circumflex coronary artery (Fig. 4).  
 
Discussion 
Although 80% of cases of meconium ileus (MI) are associated with CF, only 10-20% of CF patients 
experience this condition [1]. MI usually develops in utero, and may present in the neonate with 
complete intestinal obstruction requiring either medical or surgical intervention. The success rate of 
patients with uncomplicated MI, treated with Gastrografin enemas, ranges from 36 to 83% [2]. 
Immediate surgical intervention is required if there is evidence of intrauterine complication such as 
perforation, volvulus, or ileal atresia, or if the enema fails to relieve the obstruction after birth [2]. 
Advances in surgical techniques, total parenteral nutrition, vitamins and elemental diet, and 
perioperative care have contributed to the general improvement in the short-term survival of these 
patients [3]. Efrati et al recently reported that children and adults with CF and a history of MI as 
neonates show similar nutritional and respiratory status and survival rates as CF control patients 
without MI [3]. Furthermore, the early diagnosis of newborns with MI may be of benefit, with 
lower morbidity and increased survival [3]. Nevertheless a lethal course of MI in preterm infants 
has been described [4]. 
Sonographic characteristics of MI are neither sensitive nor specific and have been associated with 
Trisomy 21, intrauterine growth retardation, prematurity, in utero cytomegalovirus infection, 
intestinal atresia, placental abruption, and fetal demise. Furthermore hyperechogenic bowel has 
been found to be a normal variant in both the second and third trimesters, [2,5]. 
To our knowledge, this is the first case of a fetus with CF and MI complicated by myocardial 
infarction and secondary thrombosis of the left ventricle. The rapid deterioration and sudden onset 
of such severe complications	in our case prevented the opportunity to establish optimal treatment. 
A thrombophilic tendency has been described in the CF population but there is limited literature on 
precise correlation. We speculate that systemic inflammation consequent to chemical peritonitis, in 
combination with the activation of coagulative factors, was probably responsible for coronary 
thrombosis, myocardial infarction and severe dysfunction of the left ventricle with secondary 
ventricular thrombosis in our case. This hypothesis is consistent with the study of Munck et al. [6].  
The American College of Obstetrics and Gynecology and the American College of Medical 
Genetics [7,8] recommend all women of reproductive age should be offered preconception and 
prenatal CF carrier screening as a routine part of obstetric care, regardless of ethnicity. 
Nevertheless, its use is still debated. Widespread application has been limited by various ethical 
questions [9] and since not all CFTR mutations are associated with CF, the results and the detection 
rate of genetic analysis must be evaluated by a CF-experienced genetic counselor.  
In our case, if the pregnant mother had undergone prenatal CF screening, her mutation could have 
been identified and would have prompted genetic analysis of the couple, possibly predicting the 
disease of the fetus and its complications. A higher frequency of MI is expected in patients who are 
homozygous for class I–II mutations, such as F508del and N1303K [10]. 
Our case shows that where sonographic signs of MI are suspected in the fetus, a close follow up is 
necessary as these signs can be associated with severe cardiovascular complications. 
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Fig. 1: Two-dimensional view of the fetal abdomen at 32 weeks’ gestational age showing very large 
ascites. 
  
 
 
 
 
 
 
 
Fig. 2: Echocardiographic four-chamber view of the fetal heart showing dilatation of the heart 
chambers and a very large thrombus filling most of the cavity of the left ventricle. In this diastolic 
frame, Color Flow Mapping demonstrates only filling of the right ventricle. Filling of the left 
ventricle is impaired due both to severe dysfunction of its walls and the thrombus contained within. 
LA left atrium, LV left ventricle, RA right atrium, RV right ventricle, T thrombus 
 
 
 
 
 
 
 
Fig. 3: Specimen of the heart, the left ventricle and the left atrium have been opened along the 
posterolateral wall. The large thrombus is seen at the apex of the left ventricle extending along the 
interventricular septum. LA left atrium, LV left ventricle, MV mitral valve, T thrombus. 
  
 
 
 
 
 
 
Fig. 4: Short-axis section of the left coronary artery immediately distal to its bifurcation into the 
anterior descending and circumflex branch. A large thrombus is seen occluding the lumen of both 
coronaries. CX circumflex coronary artery, LAD left anterior descending coronary artery, T 
thrombus. 
 
